Cure My Disease

Don't miss your cure!

 Log in / Sign up

Workplace pain education may cut sick days by teaching employees and managers to talk about pain

NCT ID NCT07707180

Not yet recruiting Disease control Sponsor: National Research Centre for the Working Environment, Denmark Source: ClinicalTrials.gov ↗

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether a workplace program that teaches employees and managers about pain and how to communicate about it can reduce pain-related sick leave. The program includes a digital education session and a workplace needs assessment. Researchers will track sick days, pain levels, and health knowledge in about 193 employees from production workplaces.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Cognitive behavioural therapy-inspired digital education on pain and communication
What this could lead to
If it works, this program could offer a practical, low-cost way for workplaces to reduce pain-related sick leave and help employees better manage pain.
What could go wrong
This is a relatively small study in specific workplaces, so results may not apply to all settings. The program relies on voluntary participation and workplace champions, which may limit its effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

musculoskeletal system disorder occupational disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEALTHY MUSCULOSKELETAL DISORDERS OCCUPATIONAL HEALTH OCCUPATIONAL HEALTH LITERACY

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.